Related Experiment Video
Updated: Sep 27, 2025

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
20.8K
Premature Vertebral Mineralization in hmx1-Mutant Zebrafish
Younes El Fersioui1,2, Gaëtan Pinton1, Nathalie Allaman-Pillet1
1IRO-Institute for Research in Ophthalmology, 1950 Sion, Switzerland.
Cells
|April 12, 2022
Summary
Homeobox H6 family member 1 (HMX1) mutations cause oculoauricular syndrome. Zebrafish HMX1 regulates axial skeleton development by inhibiting bone morphogenetic protein (BMP) signaling.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Homeobox H6 family member 1 (HMX1) is crucial for craniofacial development.
- HMX1 mutations are associated with oculoauricular syndrome (OAS) and orofacial abnormalities.
- Altered HMX1 function can lead to skeletal defects.
Purpose of the Study:
- To investigate the role of HMX1 in axial skeleton development using zebrafish models.
- To elucidate the molecular mechanisms by which HMX1 regulates osteogenesis.
- To identify potential therapeutic targets for HMX1-related skeletal disorders.
Main Methods:
- Generated and analyzed two zebrafish mutant lines (hmx1 and hmx1) with mutations in critical HMX1 domains.
- Assessed vertebral mineralization and expression of key osteogenic and BMP signaling genes.
- Utilized DMH1, a bone morphogenetic protein (BMP) signaling inhibitor, to evaluate its effect on vertebral mineralization.
Main Results:
- Zebrafish hmx1 mutants exhibited precocious proximal vertebral mineralization.
- HMX1 deficiency led to downregulation of BMP antagonists (chordin, noggin1) and upregulation of BMPs (bmp2b, bmp4) and osteogenic promoters (runx2b, spp1).
- DMH1 treatment rescued the vertebral mineralization defect in hmx1 mutants, restoring wildtype axial skeleton development.
Conclusions:
- HMX1 acts as an inhibitor of bmp2b and bmp4 in the dorsal region during early axial skeleton development.
- HMX1 is a key component of a gene network regulating osteogenesis.
- Targeting BMP signaling may offer therapeutic strategies for HMX1-associated skeletal abnormalities.

